Three integrated entities now touch more than 70% of specialty prescriptions in the United States. The implications for net price, patient adherence and field economics are larger than most launch teams model.
All insights
Market Access
Rethinking the specialty pharmacy channel
Channel concentration has created leverage points that few manufacturers are pricing into their access strategy.
Brief
Continue reading